Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions

Journal of the National Cancer Institute

Volumn 89, Issue 19, 1997, Pages 1423-1428

  Ederer, Fred ^a,b   Church, Timothy R ^a   Mandel, Jack S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER MORTALITY; COLON CANCER; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; REHYDRATION; UNITED STATES;

EID: 0030884374     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.19.1423     Document Type: Article

References (13)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med 1993;329:672]. N Engl J Med 1993;328:1365-71.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
3. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Ahlquist DA, Moertel CG, McGill DB. Screening for colorectal cancer [letter]. N Engl J Med 1993;329:1351.
5. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994;271:1011-3.
6. Gilbertsen VA, Church TR, Grewe FJ, Mandel JS, McHugh RB, Schuman LM, et al. The design of a study to assess occult-blood screening for colon cancer. J Chronic Dis 1980;33:107-14.
7. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 1997; 89:1440-8.
8. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
9. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993;269:1262-7.
10. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545.
11. Ederer F, Church TR, Mandel JS: Sample sizes for prevention trials have been too small. Am J Epidemiol 1993;137:787-96.
12. Dukes CE. The classification of cancer of the rectum. J Pathol 1932;35: 323-32.
13. Brown ML. Screening for colorectal cancer [letter]. N Engl J Med 1993; 329:1352-3.